Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Le Hir, H.
Right arrow Articles by Thermes, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le Hir, H.
Right arrow Articles by Thermes, C.
[Cancer Research 60, 1365-1370, March 1, 2000]
© 2000 American Association for Cancer Research


Molecular Biology and Genetics

High Levels of Tyrosine Phosphorylated Proto-Ret in Sporadic Pheochromocytomas1

Hervé Le Hir2, Luca G. Colucci-D’Amato2, Nicolas Charlet-Berguerand2, Pierre-François Plouin, Xavier Bertagna, Vittorio de Franciscis and Claude Thermes3

Centre de Génétique Moléculaire, Laboratoire associé à l’Université Pierre et Marie Curie, C.N.R.S., 91190 Gif sur Yvette, France [H. L. H., N. C-B., C. T.]; Centro di Endocrinologia ed Oncologia Sperimentale del Consiglio Nazionale delle Richerche, Facoltà di Medicina e Chirurgia, 80131 Naples, Italy [L. G. C-D., V. d. F.]; Unité d’hypertension et Laboratoire de Génétique Moléculaire, Hôpital Broussais, 75014 Paris, France [P-F. P.]; and Groupe d’Etude en Physiopathologie Endocrinienne, Institut de Génétique Moléculaire, Université René Descartes, 75014 Paris 7, France [X. B.]

Pheochromocytomas are tumors originating from chromaffin cells, the large majority of which are sporadic neoplasms. The genetic and molecular events determining their tumorigenesis continue to remain unknown. On the other hand, RET germ-line mutations cause the inheritance of familial tumors in multiple endocrine neoplasia (MEN)-2 diseases, which account for a minority of pheochromocytomas. We investigated the expression of the RET gene in 14 sporadic tumors harboring no activating mutations. A subset of highly RET-expressing tumors (50%) could be distinguished. They showed RET transcript, protein amounts as well as Ret-associated phosphotyrosine levels similar to those measured in MEN-2A-associated pheochromocytomas. We also determined the GDNF and GDNF family receptor {alpha} (GFR{alpha})-1 transcript levels in tumors and in normal tissues. Whereas the GFR{alpha}-1 transcripts were detected at similar levels in normal tissues and in tumors, GDNF was frequently found expressed in sporadic tumors at levels several times higher than in controls. These results led us to propose the existence of an autocrine or paracrine loop leading to chronic stimulation of the Ret signaling pathway, which could participate in the pathogenesis of a number of sporadic pheochromocytomas.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.